New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

News Evidence That GLP-1 Drugs Achieve Weight Loss Primarily by Reducing Fat Mass More Than Muscle. Diabetes and obesity have become pressing health issues worldwide. Glucagon-lik ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

New research suggests that weight loss injections may not only help people lose weight but could also reduce the risk of ...